Suppr超能文献

三阳性抗磷脂抗体综合征患者的复发性中风和记忆丧失

Recurrent strokes and memory loss in a patient with triple-positive antiphospholipid antibody syndrome.

作者信息

Osuorji Chinenye, Bilal Jawad, Osuorji Ikenna

机构信息

Internal Medicine, Burrell College of Osteopathic Medicine, Las Cruces, New Mexico, USA

Rheumatology, University of Arizona, Tucson, Arizona, USA.

出版信息

BMJ Case Rep. 2022 Mar 25;15(3):e246104. doi: 10.1136/bcr-2021-246104.

Abstract

Antiphospholipid syndrome may cause recurrent thromboembolic events of the microvasculature, arteries and veins. It is also characterised by a range of neurological and psychiatric dysfunctions, as well as complications during pregnancy. Patients with triple-positive antiphospholipid syndrome have persistently elevated levels of lupus anticoagulant (LA), anti-beta-2-glycoprotein I (B2GPI) and anticardiolipin antibodies (aCL). These patients also have a higher risk of initial or recurrent thrombosis.We report the case of a 36-year-old man who was presented with progressive memory loss and recurrent stroke. He had persistently elevated antiphospholipid antibody titres (LA, aCL-immunoglobulin G and B2GPI antibodies). These features persisted while the patient was receiving low-dose aspirin (LDA), 81mg daily. Vitamin K antagonist (VKA); warfarin, with the international normalised ratio (INR) maintained at 2-3 was then added to his treatment regimen. The VKA dose was maintained at - a higher therapeutic INR while LDA administration was continued to achieve resolution of the patient's symptoms.

摘要

抗磷脂综合征可能导致微血管、动脉和静脉的反复血栓栓塞事件。它还具有一系列神经和精神功能障碍以及妊娠并发症的特征。抗磷脂综合征三联阳性患者的狼疮抗凝物(LA)、抗β2糖蛋白I(B2GPI)和抗心磷脂抗体(aCL)水平持续升高。这些患者发生初始或复发性血栓形成的风险也更高。我们报告了一例36岁男性患者,该患者出现进行性记忆力减退和复发性中风。他的抗磷脂抗体滴度(LA、aCL-免疫球蛋白G和B2GPI抗体)持续升高。在患者每天服用81mg低剂量阿司匹林(LDA)期间,这些特征持续存在。随后在其治疗方案中添加了维生素K拮抗剂(VKA)华法林,国际标准化比值(INR)维持在2至3。在继续服用LDA的同时,将VKA剂量维持在较高的治疗性INR水平,以缓解患者的症状。

相似文献

8
Antiphospholipid antibodies in critical illness.危重病中的抗磷脂抗体。
Crit Care Med. 2010 Feb;38(2 Suppl):S51-6. doi: 10.1097/CCM.0b013e3181c9e363.
9
Antiphospholipid syndrome.抗磷脂综合征。
Best Pract Res Clin Rheumatol. 2020 Feb;34(1):101463. doi: 10.1016/j.berh.2019.101463. Epub 2019 Dec 19.

本文引用的文献

1
Antiphospholipid syndrome.抗磷脂综合征。
Transl Res. 2020 Nov;225:70-81. doi: 10.1016/j.trsl.2020.04.006. Epub 2020 May 12.
3
Antiphospholipid syndrome.抗磷脂综合征。
Best Pract Res Clin Rheumatol. 2020 Feb;34(1):101463. doi: 10.1016/j.berh.2019.101463. Epub 2019 Dec 19.
4
EULAR recommendations for the management of antiphospholipid syndrome in adults.EULAR 成人抗磷脂综合征管理建议。
Ann Rheum Dis. 2019 Oct;78(10):1296-1304. doi: 10.1136/annrheumdis-2019-215213. Epub 2019 May 15.
5
Management of antiphospholipid syndrome.抗磷脂综合征的治疗。
Ann Rheum Dis. 2019 Feb;78(2):155-161. doi: 10.1136/annrheumdis-2018-213846. Epub 2018 Oct 3.
8
Diagnosis and Management of the Antiphospholipid Syndrome.抗磷脂综合征的诊断与管理
N Engl J Med. 2018 May 24;378(21):2010-2021. doi: 10.1056/NEJMra1705454.
9
Neurologic manifestations of antiphospholipid syndrome.抗磷脂综合征的神经系统表现
Lupus. 2018 Aug;27(9):1404-1414. doi: 10.1177/0961203318776110. Epub 2018 May 17.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验